Biotech Services
Total Trials
7
As Lead Sponsor
1
As Collaborator
6
Total Enrollment
85,593
NCT00353067
Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2006
Completion: Not specified
NCT00849563
Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes
Phase: N/A
Role: Collaborator
Start: Apr 30, 2009
Completion: Jun 30, 2013
NCT02208206
Analysis of Markers in the Blood Correlated With Neuropathic Pain
Start: Jul 31, 2014
Completion: Jan 31, 2019
NCT02523287
Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses
Phase: Phase 4
Start: Oct 2, 2014
Completion: Aug 1, 2016
NCT02487524
Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer
Start: Oct 28, 2014
Completion: Apr 22, 2016
NCT02555540
Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses
Start: Aug 24, 2015
Completion: Dec 15, 2016
NCT03327597
Iceland Screens, Treats or Prevents Multiple Myeloma
Start: Sep 1, 2016
Completion: Sep 1, 2026
Loading map...